ATH 25.0% 0.3¢ alterity therapeutics limited

AD in a dish presentation today

  1. 1,847 Posts.
    lightbulb Created with Sketch. 1
    Dr. Kim did a seminar today on the dish-

    Summary

    Cell-based model systems are powerful tools for studying signaling pathways, deciphering disease mechanisms, and predicting drug activities. Advances in stem cell technology provide new opportunities for in vitro modeling and screening in a physiologically relevant environment that is consistent and replicable. The Scientist brings together a panel of experts to discuss emerging technologies for disease modeling in regenerative medicine and stem cell therapy. Attendees will have an opportunity to interact with the experts, ask questions, and seek advice on topics that are related to their research.

    https://event.on24.com/eventRegistr...AD3B1F0E3AF8AEAB4&regTag=&sourcepage=register

    From Tom on ymb-
    Cure Alz. Webinar: Q and A:
    I submitted a question which was answered live. " Were any of the up and coming metal attenuating compounds tested for effectiveness in dissolving Ab plaques ?" Answer: "Yes ! Dr. Tanzi's team is working on that."...and he went on to say : " More interesting, I think...is testing to see if MPACs are effective in arresting aggregation of AB...and work is underway on that." I think it safe to say that news from Dr. Tanzi's lab is pertinent to Prana's interests...and therefore ours !!
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.